@article{Daud_2022, title={The Prevalence and Risk Factors of Osteoporosis and Osteopenia in Patients Aged more than 50 Years, and Adherence to Osteoporosis Treatment Guideline in a Governmental Hospital in Al-Kharj, Saudi Arabia}, volume={16}, url={http://www.asiapharmaceutics.info/index.php/ajp/article/view/4615}, DOI={10.22377/ajp.v16i4.4615}, abstractNote={<p>Aim: Osteoporosis and osteopenia are common in Saudi Arabia and the burden of management in an aging population<br>will increase in the coming decades. The study aimed to describe the prevalence of osteoporosis and osteopenia<br>among patients more than 50 years old, and identify the risk factors of these conditions, as well as the adherence<br>to the guideline for treating osteoporosis in a government hospital in Al-Kharj, Saudi Arabia. Methods: This is a<br>retrospective and case–control study performed at an orthopedic clinic in King Khaled hospital from January 2020<br>to February 2021. Data were collected retrospectively from the electronic medical records. Results: During the<br>study period, 752 patients visited the orthopedic clinic with a mean age of 69.05 (±13.575). About 13.6% of them<br>were diagnosed with osteoporosis and 15.7% of them were diagnosed with osteopenia. The risk factors of having<br>osteoporosis among the study population include being female (Odds Radio = 3.107, P = 0.001), having Vitamin D<br>deficiency (OR = 21.447, P = 0.001), and having osteoarthritis (OR = 0.459, P = 0.006). The risk factors of having<br>osteopenia among the study population include being female (OR = 2.003, P = 0.82), having Vitamin D deficiency<br>(OR = 32.657, P = 0.001), and having osteoarthritis (OR = 6.185, P = 0.001). In the present study, 97.1% of the<br>patients used an appropriate drug that is recommended by the reference guideline. Conclusions: Osteoporosis and<br>osteopenia are quite prevalent among the study population. As an early intervention, screening for osteoporosis and<br>Vitamin D levels may be proposed among Saudi individuals aged more than 50 years.</p>}, number={4}, journal={Asian Journal of Pharmaceutics (AJP)}, author={Daud, Nur Aizati Athirah}, year={2022}, month={Dec.} }